Vous êtes ici

Biocure Technology Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
CURE
Indice CSE: 
Devise: 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

Vous êtes ici

Biocure Technology Inc. (CURE)

SEDAR Information

Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: janvier 16, 2015

Information d'entreprise

Addresse
300-1055 West Hastings Street
Vancouver, BC V6E 2E9
Canada
Téléphone
604-609-7146
Fax
N/A
Courriel
admin@biocuretech.com
URL
http://www.biocuretech.com
Date d’inscription à la cote
Lundi, mai 10, 2010
Relations avec les investisseurs
n/a
Vérificateur
DMCL Chartered Professional Accountants

Advertisement

Publicité

Capitalisation

Capitalisation: 
95,597,996
Réservé à l'émission: 

Communiqués de presse

Bulletins

28/11/2017

2017-1117 – Changement Fondamental – Gravis Energy Corp./Biocure Technology Inc.

le 28 novembre/November 2017

Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.

Listing and disclosure documents will be available at thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Évènements à venir

Victor_Dodig_and_Empire-_Club_of_Canada_Website

Victor Dodig, President and CEO of CIBC

Mardi, septembre 11, 2018 (Jour entier)
09_13_CSE_Talks_Cannabis_In_the_Capital_Markets_Website

CSE Talks: Cannabis In the Capital Markets

Jeudi, septembre 13, 2018 -
15:00 - 18:00
Extraordinary Future Header 2018

Extraordinary Future

Mercredi, septembre 19, 2018 (Jour entier) - Jeudi, septembre 20, 2018 (Jour entier)